Promise Pharmacy recalls Prednisolone/Gatifloxacin eye drops with precipitate risk
Promise Pharmacy LLC recalls 1%/0.5% Prednisolone and Gatifloxacin Ophthalmic Solution due to potential precipitate. This may affect eye safety. Contact for details.
Lower-risk recall
Presence of precipitate
Contact the company
What happened, in plain English
Promise Pharmacy LLC is recalling prednisolone and gatifloxacin eye drops that may contain precipitate. This could cause eye irritation or injury if used. Read more at govinfonow.com/recall/39489-promise-pharmacy-recalls-prednisolone-gatifloxacin-eye-drops-with-precipitate-risk.
Source Summary by GovInfoNow · govinfonow.com/recall/39489-promise-pharmacy-recalls-prednisolone-gatifloxacin-eye-drops-with-precipitate-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0239-2019
Cite this page
“Promise Pharmacy recalls Prednisolone/Gatifloxacin eye drops with precipitate risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/39489-promise-pharmacy-recalls-prednisolone-gatifloxacin-eye-drops-with-precipitate-risk. Based on FDA recall #D-0239-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0239-2019%22&limit=1).
Why it’s dangerous
Precipitate can form in the eye drop solution, potentially causing irritation or injury when used. This is a chemical issue that may not be visible to the user.
Who’s affected
People with prescriptions for these eye drops from Promise Pharmacy in Palm Harbor, Florida. Those with the specific lot number 04092018@2 are most at risk.
How to tell if you have this one
Check for the 3 mL dropper bottle labeled Prednisolone and Gatifloxacin Ophthalmic Solution, 1%/0.5%. The lot number 04092018@2 is associated with this recall.
- Brand
Promise Pharmacy- Category
Drug
What to do — step by step
Check Product Details
Look for the lot number 04092018@2 on the bottle label to confirm if it's affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “U.S.A. Nationwide.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 2 years after the firm started it.
- Firm started the recall
- Published in FDA’s Enforcement Report
- FDA classified it Class III
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0239-2019 (October 18, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0239-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.